Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Says NMPA Approved Registration & Commercialisation Of Single-Dose Beifushu Eye Drops In PRC

Dec 27 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * UNIT OBTAINED APPROVAL FROM NMPA FOR REGISTRATION &
COMMERCIALISATION OF PRESERVATIVE-FREE SINGLE-DOSE BEIFUSHU EYE
DROPS IN PRC

Source text for Eikon:  urn:newsml:reuters.com:*:nHKS6l70h5
Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news